Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Rodney L. Parsons is active.

Publication


Featured researches published by Rodney L. Parsons.


Journal of Organic Chemistry | 2009

Process Research and Development for a Tetrazole-Based Growth Hormone Secretagogue (GHS) Pharmaceutical Development Candidate

Akin H. Davulcu; Douglas D. McLeod; Jun Li; Kishta Katipally; Adam F. Littke; Wendel W. Doubleday; Zhongmin Xu; Cary W. McConlogue; Chiajen J. Lai; Margaret Gleeson; Mark D. Schwinden; Rodney L. Parsons

BMS-317180 (1) is a potent, orally active agonist of the human growth hormone secretagogue (GHS) receptor. This manuscript details the process research and development efforts that enabled the synthesis of the phosphate salt of 1 on a multi-kilogram scale. Key considerations in the development of this process focused on safe execution and the requirement for telescoped synthetic transformations (i.e., without isolation of intermediate products) to contend with a lack of suitably crystalline products.


Separation Science and Technology | 2011

Analytical Considerations for Genotoxic and Other Impurities

Rodney L. Parsons; Scott A. Miller

Abstract Recent regulatory guidelines for the control of genotoxic impurities in pharmaceutical products have posed a significant challenge for the pharmaceutical industry. This chapter provides an overview of the regulatory requirements, evolution of the established exposure limits, assessment of genotoxic impurities, and the implementation and execution of an appropriate risk-based genotoxic control strategy. In addition, an overview of the analytical challenges, methodologies, and strategy for testing genotoxic impurities at trace levels in pharmaceutical products is provided.


Journal of Organic Chemistry | 1998

Practical Asymmetric Synthesis of Efavirenz (DMP 266), an HIV-1 Reverse Transcriptase Inhibitor

Michael E. Pierce; Rodney L. Parsons; Lilian A. Radesca; Young Sek Lo; Stuart Silverman; James R. Moore; Qamrul Islam; Anusuya Choudhury; Joseph M. Fortunak; Dieu Nguyen; Chi Luo; Susan J. Morgan; Wayne P. Davis; Pat N. Confalone; Cheng-yi Chen; Richard D. Tillyer; Lisa F. Frey; Lushi Tan; Feng Xu; Dalian Zhao; Andrew S. Thompson; Edward G. Corley; Edward J. J. Grabowski; Robert A. Reamer; Paul J. Reider


Organic Letters | 2000

An Efficient Chiral Moderator Prepared from Inexpensive (+)-3-Carene: Synthesis of the HIV-1 Non-Nucleoside Reverse Transcriptase Inhibitor DPC 963

Goss S. Kauffman; Gregory D. Harris; Roberta L. Dorow; Benjamin R. P. Stone; Rodney L. Parsons; Jaan A. Pesti; Nicholas A. Magnus; Joseph M. Fortunak; Pat N. Confalone; William A. Nugent


Organic Process Research & Development | 2005

Process Development Challenges to Accommodate A Late-Appearing Stable Polymorph: A Case Study on the Polymorphism and Crystallization of a Fast-Track Drug Development Compound

Sridhar Desikan; Rodney L. Parsons; Wayne P. Davis; James E. Ward; Will J. Marshall; Pascal H. Toma


Journal of the American Chemical Society | 2004

Structural and Rate Studies of the 1,2-Additions of Lithium Phenylacetylide to Lithiated Quinazolinones: Influence of Mixed Aggregates on the Reaction Mechanism

Timothy F. Briggs; Mark D. Winemiller; David B. Collum; Rodney L. Parsons; Akin H. Davulcu; Gregory D. Harris; Joseph M. Fortunak; Pat N. Confalone


Journal of Organic Chemistry | 2003

General scope of 1,4-diastereoselective additions to a 2(3H)-quinazolinone: practical preparation of HIV therapeutics.

Nicholas A. Magnus; Pat N. Confalone; Louis Storace; Mona Patel; Christopher C. Wood; Wayne P. Davis; Rodney L. Parsons


Organic Process Research & Development | 2002

An Efficient Large-Scale Process for the Human Leukocyte Elastase Inhibitor, DMP 7771

Louis Storace; Luigi Anzalone; Pat N. Confalone; Wayne P. Davis; Joseph M. Fortunak; Mark Giangiordano; James J. Haley; Kenneth Kamholz; Hui-Yin Li; Philip Ma; William A. Nugent; Rodney L. Parsons; Patrick J. Sheeran; Charlotte E. Silverman; and Robert E. Waltermire; Christopher C. Wood


Journal of Organic Chemistry | 1993

Total synthesis of strychnan- and aspidospermatan-type alkaloids. 2. Generation of 15-(3-furanyl) ABCE tetracyclic intermediates

Rodney L. Parsons; Jeffrey D. Berk; Martin E. Kuehne


Organic Process Research & Development | 2010

Development of a Scaleable Process for the Synthesis of a Next-Generation Statin

Lindsay A. Hobson; Otute Akiti; Subodh S. Deshmukh; Shannon Harper; Kishta Katipally; Chiajen J. Lai; Robert C. Livingston; Ehrlic Lo; Michael M. Miller; Srividya Ramakrishnan; Lifen Shen; Jan Spink; Srinivas Tummala; Chenkou Wei; Kana Yamamoto; John Young; Rodney L. Parsons

Collaboration


Dive into the Rodney L. Parsons's collaboration.

Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Jun Li

Bristol-Myers Squibb

View shared research outputs
Top Co-Authors

Avatar
Researchain Logo
Decentralizing Knowledge